Neuronetics (STIM) Income from Continuing Operations (2017 - 2026)
Neuronetics (STIM) posted quarterly Income from Continuing Operations of 11261000.0 for Q1 2026, up 13.96% year-over-year from 9881593.56 in Q1 2025, and down 51.48% quarter-over-quarter from 7434000.0 in Q4 2025.
Neuronetics (STIM) Income from Continuing Operations (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has reported Income from Continuing Operations for 10 consecutive years, with 11261000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 13.96% year-over-year to 11261000.0; the TTM figure through Mar 2026 stood at 48987000.0 (down 4.21% YoY), while the FY2025 annual figure was 39851000.0, up 76.36% from the prior year.
- Income from Continuing Operations fell to 11261000.0 in Q1 2026 per STIM's latest filing, from 7434000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 6097000.0 in Q4 2023 and bottomed at 18193000.0 in Q2 2025.
- Historically, Income from Continuing Operations has averaged 10837882.35 across 5 years, with a median of 10611000.0 in 2024.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations jumped 56.22% — and 2024, when it slumped 127.29%.
- Neuronetics' Income from Continuing Operations stood at 8827000.0 in 2022, then jumped by 30.93% to 6097000.0 in 2023, then tumbled by 127.29% to 13858000.0 in 2024, then surged by 46.36% to 7434000.0 in 2025, then tumbled by 51.48% to 11261000.0 in 2026.
- Business Quant data shows STIM's Income from Continuing Operations at 11261000.0 in Q1 2026, 7434000.0 in Q4 2025, and 12099000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Neuronetics | 225.97 Mn | 206.54 Mn | 21.22 Mn | -3.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -39.10 Mn |
| Mar 31, 2026 | -11.26 Mn |
| Dec 31, 2025 | -7.43 Mn |
| Sep 30, 2025 | -12.10 Mn |
| Jun 30, 2025 | -18.19 Mn |
| Mar 31, 2025 | -13.09 Mn |
| Dec 31, 2024 | -13.86 Mn |
| Sep 30, 2024 | -9.45 Mn |
| Jun 30, 2024 | -10.61 Mn |
| Mar 31, 2024 | -8.69 Mn |
| Dec 31, 2023 | -6.10 Mn |
| Sep 30, 2023 | -10.06 Mn |
| Jun 30, 2023 | -8.35 Mn |
| Mar 31, 2023 | -11.16 Mn |
| Dec 31, 2022 | -8.83 Mn |
| Sep 30, 2022 | -8.71 Mn |
| Jun 30, 2022 | -11.09 Mn |
| Mar 31, 2022 | -15.27 Mn |
| Dec 31, 2021 | -7.74 Mn |
| Sep 30, 2021 | -12.79 Mn |